世界の脊椎骨刺激装置市場2020年-2030年:装置タイプ別(侵襲性脊椎骨刺激装置、非侵襲性脊椎骨刺激装置)、エンドユーザー別

【英語タイトル】Spine Bone Stimulators Market By Device Type (Invasive Spine Bone Stimulators, Non-Invasive Spine Bone Stimulators), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Allied Market Researchが出版した調査資料(ALD22JL085)・商品コード:ALD22JL085
・発行会社(調査会社):Allied Market Research
・発行日:2022年4月
・ページ数:172
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,398 ⇒換算¥650,904見積依頼/購入/質問フォーム
5 UserUSD4,803 ⇒換算¥710,844見積依頼/購入/質問フォーム
Enterprise UserUSD7,698 ⇒換算¥1,139,304見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Allied Market Research社発行の当調査レポートでは、世界の脊椎骨刺激装置市場について広く調査・分析し、イントロダクション、エグゼクティブサマリー、市場概要、装置タイプ別(侵襲性脊椎骨刺激装置、非侵襲性脊椎骨刺激装置)分析、エンドユーザー別(病院、専門クリニック、その他)分析、地域別分析、企業状況、企業情報などの内容をまとめております。当書に掲載されている企業情報には、Enovis (DJO Global, Inc.)、Zimmer Biomet、Orthofix Medical Inc.、Elizur Corporation、Ossatec Benelux BV、IGEA S.p.A. 、ManaMed Inc.、Theragen, Inc.、Intelligent Implants、Orchid Medical, Inc.などが含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の脊椎骨刺激装置市場規模:装置タイプ別(侵襲性脊椎骨刺激装置、非侵襲性脊椎骨刺激装置)
・世界の脊椎骨刺激装置市場規模:エンドユーザー別(病院、専門クリニック、その他)
・世界の脊椎骨刺激装置市場規模:地域別
・企業状況
・企業情報

Spine bone stimulators are used during a spinal fusion surgery along with spinal instrumentation (plates, rods, andscrews) and bone grafts. Their main function is to enhance the bone’s healing process, which is essential for spinalfusion procedure and are typically worn after this surgery. A bone stimulator, internal or external, is a small device thatdelivers low-voltage electrical currents directly to the spinal area where bone growth (spine fusion) is about to occur.
The key factors that drive the market growth include increase in geriatric population and rise in incidence of osteoporosis & arthritis. However, advent of bone growth-stimulating drugs and fixation instrumentation during fusion and non-union fractures are expected to impede this market growth.

The report segments the market on the basis of device type, end user, and region. On the basis of device type, the market is bifurcated into non-invasive and invasive spine bone stimulators. By end user, it is divided into hospital, specialty clinic, and end user. By region, it is analyzed across North America, Europe, Asia Pacific, and LAMEA.

The major companies profiled in this report include Enovis (DJO Global, Inc.), Zimmer Biomet. Orthofix Medical Inc., Elizur Corporation, Ossatec Benelux BV, Orchid Medical, Inc., IGEA S.p.A., ManaMed Inc., Theragen, Inc. Intelligent Implants

KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the spine bone stimulators market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

Key Market Segments
By Device Type
Invasive Spine Bone Stimulators
Non-Invasive Spine Bone Stimulators
Pulsed Electromagnetic Field (PEMF) Devices
Capacitive Coupling (CC) and Combined Magnetic Field (CMF) Devices

By End User
Hospitals
Specialty Clinics
Others

By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players
Enovis (DJO Global, Inc.)
Zimmer Biomet
Orthofix Medical Inc.
Elizur Corporation
Ossatec Benelux BV
IGEA S.p.A. 
ManaMed Inc.
Theragen, Inc.
Intelligent Implants
Orchid Medical, Inc.

❖ レポートの目次 ❖

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: SPINE BONE STIMULATORS MARKET, BY DEVICE TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Invasive Spine Bone Stimulators
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Non-Invasive Spine Bone Stimulators
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: SPINE BONE STIMULATORS MARKET, BY END USER
5.1 Overview
5.1.1 Market size and forecast
5.2 Hospitals
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Specialty Clinics
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: SPINE BONE STIMULATORS MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Device Type
6.2.3 North America Market size and forecast, by End User
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Device Type
6.2.4.1.2 Market size and forecast, by End User
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Device Type
6.2.4.2.2 Market size and forecast, by End User
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Device Type
6.2.4.3.2 Market size and forecast, by End User
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Device Type
6.3.3 Europe Market size and forecast, by End User
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Device Type
6.3.4.1.2 Market size and forecast, by End User
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Device Type
6.3.4.2.2 Market size and forecast, by End User
6.3.4.3 U.K.
6.3.4.3.1 Market size and forecast, by Device Type
6.3.4.3.2 Market size and forecast, by End User
6.3.4.4 Italy
6.3.4.4.1 Market size and forecast, by Device Type
6.3.4.4.2 Market size and forecast, by End User
6.3.4.5 Spain
6.3.4.5.1 Market size and forecast, by Device Type
6.3.4.5.2 Market size and forecast, by End User
6.3.4.6 Rest of Europe
6.3.4.6.1 Market size and forecast, by Device Type
6.3.4.6.2 Market size and forecast, by End User
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Device Type
6.4.3 Asia-Pacific Market size and forecast, by End User
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 Japan
6.4.4.1.1 Market size and forecast, by Device Type
6.4.4.1.2 Market size and forecast, by End User
6.4.4.2 China
6.4.4.2.1 Market size and forecast, by Device Type
6.4.4.2.2 Market size and forecast, by End User
6.4.4.3 Australia
6.4.4.3.1 Market size and forecast, by Device Type
6.4.4.3.2 Market size and forecast, by End User
6.4.4.4 India
6.4.4.4.1 Market size and forecast, by Device Type
6.4.4.4.2 Market size and forecast, by End User
6.4.4.5 South Korea
6.4.4.5.1 Market size and forecast, by Device Type
6.4.4.5.2 Market size and forecast, by End User
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Market size and forecast, by Device Type
6.4.4.6.2 Market size and forecast, by End User
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Device Type
6.5.3 LAMEA Market size and forecast, by End User
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Market size and forecast, by Device Type
6.5.4.1.2 Market size and forecast, by End User
6.5.4.2 Saudi Arabia
6.5.4.2.1 Market size and forecast, by Device Type
6.5.4.2.2 Market size and forecast, by End User
6.5.4.3 South Africa
6.5.4.3.1 Market size and forecast, by Device Type
6.5.4.3.2 Market size and forecast, by End User
6.5.4.4 Rest of LAMEA
6.5.4.4.1 Market size and forecast, by Device Type
6.5.4.4.2 Market size and forecast, by End User
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Enovis (DJO Global, Inc.)
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Zimmer Biomet
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Orthofix Medical Inc.
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Elizur Corporation
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Ossatec Benelux BV
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 IGEA S.p.A. 
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 ManaMed Inc.
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Theragen, Inc.
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Intelligent Implants
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Orchid Medical, Inc.
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL SPINE BONE STIMULATORS MARKET, BY DEVICE TYPE, 2020-2030,($MILLION)
TABLE 2. SPINE BONE STIMULATORS MARKET REVENUE, FOR INVASIVE SPINE BONE STIMULATORS, BY REGION , 2020-2030,($MILLION)
TABLE 3. SPINE BONE STIMULATORS MARKET INVASIVE SPINE BONE STIMULATORS BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. SPINE BONE STIMULATORS MARKET REVENUE, FOR NON-INVASIVE SPINE BONE STIMULATORS, BY REGION , 2020-2030,($MILLION)
TABLE 5. SPINE BONE STIMULATORS MARKET NON-INVASIVE SPINE BONE STIMULATORS BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. GLOBAL SPINE BONE STIMULATORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 7. SPINE BONE STIMULATORS MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION)
TABLE 8. SPINE BONE STIMULATORS MARKET HOSPITALS BY COUNTRY, 2020-2030,($MILLION)
TABLE 9. SPINE BONE STIMULATORS MARKET REVENUE, FOR SPECIALTY CLINICS, BY REGION , 2020-2030,($MILLION)
TABLE 10. SPINE BONE STIMULATORS MARKET SPECIALTY CLINICS BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. SPINE BONE STIMULATORS MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 12. SPINE BONE STIMULATORS MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. SPINE BONE STIMULATORS MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 14. NORTH AMERICA SPINE BONE STIMULATORS MARKET, BY DEVICE TYPE, 2020-2030,($MILLION)
TABLE 15. NORTH AMERICA SPINE BONE STIMULATORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 16. NORTH AMERICA SPINE BONE STIMULATORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 17. U.S. SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 18. U.S. SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 19. CANADA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 20. CANADA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 21. MEXICO SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 22. MEXICO SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 23. EUROPE SPINE BONE STIMULATORS MARKET, BY DEVICE TYPE, 2020-2030,($MILLION)
TABLE 24. EUROPE SPINE BONE STIMULATORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 25. EUROPE SPINE BONE STIMULATORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 26. GERMANY SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 27. GERMANY SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 28. FRANCE SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 29. FRANCE SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 30. U.K. SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 31. U.K. SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 32. ITALY SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 33. ITALY SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 34. SPAIN SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 35. SPAIN SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 36. REST OF EUROPE SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 37. REST OF EUROPE SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 38. ASIA-PACIFIC SPINE BONE STIMULATORS MARKET, BY DEVICE TYPE, 2020-2030,($MILLION)
TABLE 39. ASIA-PACIFIC SPINE BONE STIMULATORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 40. ASIA-PACIFIC SPINE BONE STIMULATORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 41. JAPAN SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 42. JAPAN SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 43. CHINA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 44. CHINA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 45. AUSTRALIA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 46. AUSTRALIA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 47. INDIA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 48. INDIA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 49. SOUTH KOREA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 50. SOUTH KOREA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 51. REST OF ASIA-PACIFIC SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 52. REST OF ASIA-PACIFIC SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 53. LAMEA SPINE BONE STIMULATORS MARKET, BY DEVICE TYPE, 2020-2030,($MILLION)
TABLE 54. LAMEA SPINE BONE STIMULATORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 55. LAMEA SPINE BONE STIMULATORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 56. BRAZIL SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 57. BRAZIL SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 58. SAUDI ARABIA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 59. SAUDI ARABIA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 60. SOUTH AFRICA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 61. SOUTH AFRICA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 62. REST OF LAMEA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)
TABLE 63. REST OF LAMEA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 64.ENOVIS (DJO GLOBAL, INC.): COMPANY SNAPSHOT
TABLE 65.ENOVIS (DJO GLOBAL, INC.): OPERATING SEGMENTS
TABLE 66.ENOVIS (DJO GLOBAL, INC.): PRODUCT PORTFOLIO
TABLE 67.ENOVIS (DJO GLOBAL, INC.): NET SALES,
TABLE 68.ENOVIS (DJO GLOBAL, INC.): KEY STRATERGIES
TABLE 69.ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 70.ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 71.ZIMMER BIOMET: PRODUCT PORTFOLIO
TABLE 72.ZIMMER BIOMET: NET SALES,
TABLE 73.ZIMMER BIOMET: KEY STRATERGIES
TABLE 74.ORTHOFIX MEDICAL INC.: COMPANY SNAPSHOT
TABLE 75.ORTHOFIX MEDICAL INC.: OPERATING SEGMENTS
TABLE 76.ORTHOFIX MEDICAL INC.: PRODUCT PORTFOLIO
TABLE 77.ORTHOFIX MEDICAL INC.: NET SALES,
TABLE 78.ORTHOFIX MEDICAL INC.: KEY STRATERGIES
TABLE 79.ELIZUR CORPORATION: COMPANY SNAPSHOT
TABLE 80.ELIZUR CORPORATION: OPERATING SEGMENTS
TABLE 81.ELIZUR CORPORATION: PRODUCT PORTFOLIO
TABLE 82.ELIZUR CORPORATION: NET SALES,
TABLE 83.ELIZUR CORPORATION: KEY STRATERGIES
TABLE 84.OSSATEC BENELUX BV: COMPANY SNAPSHOT
TABLE 85.OSSATEC BENELUX BV: OPERATING SEGMENTS
TABLE 86.OSSATEC BENELUX BV: PRODUCT PORTFOLIO
TABLE 87.OSSATEC BENELUX BV: NET SALES,
TABLE 88.OSSATEC BENELUX BV: KEY STRATERGIES
TABLE 89.IGEA S.P.A. : COMPANY SNAPSHOT
TABLE 90.IGEA S.P.A. : OPERATING SEGMENTS
TABLE 91.IGEA S.P.A. : PRODUCT PORTFOLIO
TABLE 92.IGEA S.P.A. : NET SALES,
TABLE 93.IGEA S.P.A. : KEY STRATERGIES
TABLE 94.MANAMED INC.: COMPANY SNAPSHOT
TABLE 95.MANAMED INC.: OPERATING SEGMENTS
TABLE 96.MANAMED INC.: PRODUCT PORTFOLIO
TABLE 97.MANAMED INC.: NET SALES,
TABLE 98.MANAMED INC.: KEY STRATERGIES
TABLE 99.THERAGEN, INC.: COMPANY SNAPSHOT
TABLE 100.THERAGEN, INC.: OPERATING SEGMENTS
TABLE 101.THERAGEN, INC.: PRODUCT PORTFOLIO
TABLE 102.THERAGEN, INC.: NET SALES,
TABLE 103.THERAGEN, INC.: KEY STRATERGIES
TABLE 104.INTELLIGENT IMPLANTS: COMPANY SNAPSHOT
TABLE 105.INTELLIGENT IMPLANTS: OPERATING SEGMENTS
TABLE 106.INTELLIGENT IMPLANTS: PRODUCT PORTFOLIO
TABLE 107.INTELLIGENT IMPLANTS: NET SALES,
TABLE 108.INTELLIGENT IMPLANTS: KEY STRATERGIES
TABLE 109.ORCHID MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 110.ORCHID MEDICAL, INC.: OPERATING SEGMENTS
TABLE 111.ORCHID MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 112.ORCHID MEDICAL, INC.: NET SALES,
TABLE 113.ORCHID MEDICAL, INC.: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.SPINE BONE STIMULATORS MARKET SEGMENTATION
FIGURE 2.SPINE BONE STIMULATORS MARKET,2020-2030
FIGURE 3.SPINE BONE STIMULATORS MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.SPINE BONE STIMULATORS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.SPINE BONE STIMULATORS MARKET,BY DEVICE TYPE,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF INVASIVE SPINE BONE STIMULATORS SPINE BONE STIMULATORS MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE SPINE BONE STIMULATORS SPINE BONE STIMULATORS MARKET,2020-2030(%)
FIGURE 14.SPINE BONE STIMULATORS MARKET,BY END USER,2020(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF HOSPITALS SPINE BONE STIMULATORS MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF SPECIALTY CLINICS SPINE BONE STIMULATORS MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS SPINE BONE STIMULATORS MARKET,2020-2030(%)
FIGURE 18.SPINE BONE STIMULATORS MARKET BY REGION,2020
FIGURE 19.U.S. SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 20.CANADA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 21.MEXICO SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 22.GERMANY SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 23.FRANCE SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 24.U.K. SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 25.ITALY SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 26.SPAIN SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 27.REST OF EUROPE SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 28.JAPAN SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 29.CHINA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 30.AUSTRALIA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 31.INDIA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 32.SOUTH KOREA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 33.REST OF ASIA-PACIFIC SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 34.BRAZIL SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 35.SAUDI ARABIA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 36.SOUTH AFRICA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 37.REST OF LAMEA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)
FIGURE 38. TOP WINNING STRATEGIES, BY YEAR
FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 41.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 42.COMPETITIVE DASHBOARD
FIGURE 43.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 44.ENOVIS (DJO GLOBAL, INC.).: NET SALES ,($MILLION)
FIGURE 45.ZIMMER BIOMET.: NET SALES ,($MILLION)
FIGURE 46.ORTHOFIX MEDICAL INC..: NET SALES ,($MILLION)
FIGURE 47.ELIZUR CORPORATION.: NET SALES ,($MILLION)
FIGURE 48.OSSATEC BENELUX BV.: NET SALES ,($MILLION)
FIGURE 49.IGEA S.P.A. .: NET SALES ,($MILLION)
FIGURE 50.MANAMED INC..: NET SALES ,($MILLION)
FIGURE 51.THERAGEN, INC..: NET SALES ,($MILLION)
FIGURE 52.INTELLIGENT IMPLANTS.: NET SALES ,($MILLION)
FIGURE 53.ORCHID MEDICAL, INC..: NET SALES ,($MILLION)

★調査レポート[世界の脊椎骨刺激装置市場2020年-2030年:装置タイプ別(侵襲性脊椎骨刺激装置、非侵襲性脊椎骨刺激装置)、エンドユーザー別] (コード:ALD22JL085)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の脊椎骨刺激装置市場2020年-2030年:装置タイプ別(侵襲性脊椎骨刺激装置、非侵襲性脊椎骨刺激装置)、エンドユーザー別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆